December 30, 2009 at 19:04 PM EST
Generic-Drug Firms Prosper Amid Drive To Cut Health Costs
Wade through all the fevered rhetoric surrounding health care reform, and you'll find one point nearly everyone agrees on: Anything that can lower costs is a good thing. That partly explains why generic-drug makers have enjoyed a months-long rally on Wall Street despite the manic ebb and flow of the reform debate. Generic drugs save patients money. Many are 70% cheaper than their name-brand counterparts. Patients saved an estimated $121 billion in
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here